Research Snapshot: Genetics may predict benefits of kava in reducing lung cancer risk
Researchers bolstered their findings that kava may reduce lung cancer risk caused by tobacco smoke.
Researchers bolstered their findings that kava may reduce lung cancer risk caused by tobacco smoke.
The study will explore the potential for kava to serve as a tobacco cessation aid.
The study will evaluate the potential of AB-free kava against tobacco smoke-induced lung cancer.
Kava’s reputation in preventing cancer just received a boost from the American Association for Cancer Research. The May cover of the organization’s flagship journal, Cancer Prevention Research, featured a clinical study on kava led by Chengguo “Chris” Xing, Ph.D., a professor of medicinal chemistry and the Frank A. Duckworth Eminent Scholar Chair in the UF College of Pharmacy and a member of the UF Health Cancer Center.